---
schema_version: "secwatch.filing_event.v1"
accession: "0001558370-25-008600"
form_type: "8-K"
ticker: "PMN"
cik: "0001374339"
company_name: "ProMIS Neurosciences Inc."
filed_at: "2025-06-13T23:59:59+00:00"
generated_at: "2026-05-19T07:45:59.929550+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.4
calibrated_materiality_score: 0.4
confidence: "high"
source: SEC EDGAR
---

# ProMIS Neurosciences shareholders approve 2025 stock plan and reelect directors

## Summary
- Shareholders approved 2025 Stock Option and Incentive Plan: 8,124,425 for, 828,874 against, 1,143,067 abstain.
- All seven director nominees elected, including CEO Neil Warma, with no major withhold votes.
- Ratification of Baker Tilly US, LLP as auditor for fiscal 2025 passed with 16,908,296 votes for.
- New plan replaces 2015 Plan, authorizes 2,946,719 initial shares plus annual 5% of outstanding shares on Jan 1 each year.

## SEC filing metadata
- accession: 0001558370-25-008600
- form_type: 8-K
- ticker: PMN
- cik: 0001374339
- company_name: ProMIS Neurosciences Inc.
- filed_at: 2025-06-13T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.4
- calibrated_materiality_score: 0.4
- confidence: high
- sec_items: 5.02, 5.07, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1374339/000155837025008600/0001558370-25-008600-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1374339/000155837025008600/pmn-20250612x8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001558370-25-008600
- JSON: https://secwatch.observer/filing/0001558370-25-008600.json
- Plain text: https://secwatch.observer/filing/0001558370-25-008600.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.